- Share
-
-
-
-
A substantial percentage of people receiving prolonged treatment with antipsychotics may develop Tardive Dyskinesia (TD), an involuntary movement disorder characterized by repetitive and uncontrollable movements. Experts believe that some form of TD now affects an estimated 750,000 people in the U.S. alone. Despite the social, emotional, and physical impact it can have on patients, only about 15-25% of people with the disorder are formally diagnosed, and those with this condition and their families often have difficulty with assessment and management. TD imposes a substantial burden on individuals’ physical functioning, mental well-being, and social activities, even in people with self-assessed mild-to-moderate TD symptoms.
Sherland Peterson will discuss the personal impact that TD has had on her own life and how she has lived with and learned to thrive with TD. Bill Cote, Senior Director of the National Organization for Tardive Dyskinesia, will speak about the individuals across the country living with this condition, the resources available to improve quality of life, and how families and community members can provide support through increased awareness and education.
Learning Objectives:
Understand the symptoms of TD and its impact on a person’s health, well-being, and daily functioning.
Understand the factors that increase a person’s risk for developing TD.
Identify keyways to support someone living with TD in their daily life.
Gain knowledge of resources, management tools and self-care strategies including TD triggers to avoid.
Review key behaviors and symptoms and what to watch out for in yourself and people around you.
